ALK inhibitors suppress HCC and synergize with anti-PD-1 therapy and ABT-263 in preclinical models

Study the differential gene expression in SK-MEL-147 cells treated with different epigenetic modulator

HOXC6 drives a therapeutically targetable pancreatic cancer growth and metastasis pathway via stimulating MSK1 kinase and suppressing PPP2R2B protein

HOXC6 drives a therapeutically targetable pancreatic cancer growth and metastasis pathway via stimulating MSK1 kinase and suppressing PPP2R2B protein

LIMK2 promotes melanoma tumor growth and metastasis through G3BP1-ESM1 pathway-mediated apoptosis inhibition

CBX5 loss drives EGFR inhibitor resistance and results in therapeutically actionable vulnerabilities in lung cancer

Transcriptional, chromatin, and metabolic landscapes of LDHA inhibitor–resistant pancreatic ductal adenocarcinoma

Study the differential gene expression of different lung cancer EGFR mutants in NIH3T3 cells

Study the differential gene expression of C57/BL6 Mouse tumors treated with EZH2 inhibitor GSK343 II

Study the differential gene expression of HEPA1-6 tumors in C57/BL6 Mouse tumors treated with vehicle or EZH2 inhibitor GSK343

The role of MELK in melanoma progression

Loss of thymidine kinase 1 inhibits lung cancer growth and metastatic attributes by reducing GDF15 expression

Transcriptome-wide gene expression analysis of the cancer cell lines after treatiment with telomerase inhibitor Imetelstat (GRN163L)

Metabolic drivers of ovarian cancer tumor growth

Transcriptional targets of oncogenic RAS proteins that mediate their ability to induce cellular transformation

Regulators of NRAS-mediated transformation and melanoma tumor maintenance

Oncogenic EGFR Represses the TET1 DNA Demethylase to Induce Silencing of Tumor Suppressors in Cancer Cells

PEA15 regulates the DNA damage induced cell cycle checkpoint and oncogene-directed transformation

miR-146a promotes the initiation and progression of melanoma by activating Notch signaling

miR-146a promotes the initiation and progression of melanoma by activating Notch signaling